Yael Shachor-Meyouhas

6PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Infectious diseasesHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
Risk Factors for Severe Outcomes Among Pediatric Cancer Patients with Respiratory Viral Infection.

Alon Kristal, Avi Magid, Nira Arad-Cohen

|Aug 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose.

Avi Magid, Khetam Hussein, Halima Dabaja-Younis

|Apr 10, 2023
Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.

Adi Anafy, Gil Gilad, Nadav Michaan

|Feb 28, 2023
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers.

Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid

|Oct 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers.

Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen

|Jul 27, 2022
Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort Study.

Meital Elbaz, Maya Korem, Oshrat Ayalon

Pageof 1

Frequent Collaborators

3 joint publications

Michael Halberthal

3 joint publications

Avi Magid

2 joint publications

Khetam Hussein

1 joint publications

Oshrat Ayalon